Prostate cancer has become one of the most prevalent diseases globally, which affects millions of men, and is estimated to go up to 288.3 thousand patients in the U.S. in 2023. Therefore, its diagnosis and management process need innovations and continuous improvements to reduce morbidity and mortality rates. The advancement of robotic surgery, defined by its minimally invasive method, has changed the game. It is superior to open surgery practice, with fewer complications after the operation time, quicker recovery, and improved lifestyle. This systematic review rigorously and systematically analyzes studies of this kind and addresses the various operative outcomes, including wound complications, surgical site infections, and urinary and sexual functions. This systematic review will be explorative, aiming to establish the benefits of robotic surgery in terms of postoperative outcomes. We intend to contribute to the cardio-thoracic surgical literature by providing a comprehensive analysis of how this type of surgery affects the postoperative recovery of patients with prostate cancer, giving recommendations for future clinical care and research in this field.
No takes yet. Share an insight, caveat, or question.
Ortiz et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: